Lord, Abbett & Co
BNTX icon

Lord, Abbett & Co’s BioNTech BNTX Stock Holding History

Lord, Abbett & Co’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-605,251
Closed -$156M – 613
2021
Q4 		$156M Buy
+605,251
New +$166M 0.36% 77
2021
Q1 		– Sell
-244,253
Closed -$19.9M – 643
2020
Q4 		$19.9M Sell
244,253
-108,290
-31% -$10.6M 0.05% 411
2020
Q3 		$24.4M Buy
+352,543
New +$25.3M 0.08% 345

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Lord, Abbett & Co's BNTX Position: Q1 2022 in Review

Lord, Abbett & Co sold out of BioNTech (BNTX) in Q1 2022, closing a stake of 605,251 shares — an estimated $156M sold.

Lord, Abbett & Co first reported a position in BNTX in Q3 2020 and held it in 3 quarters. The position peaked at $156M in Q4 2021. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2022.

  • Lord, Abbett & Co reported no remaining BioNTech position as of Q1 2022 after selling out during the quarter.
  • Lord, Abbett & Co sold 605,251 BioNTech shares in Q1 2022, an estimated $156M.
  • Lord, Abbett & Co first reported a position in BioNTech in Q3 2020 and held it in 3 quarters.
  • Lord, Abbett & Co's BioNTech position peaked at $156M in Q4 2021.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2022.

Based on Lord, Abbett & Co's 13F filing for Q1 2022, filed 13 May 2022.